Blog
About

5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To critically appraise published network meta-analyses (NMAs) evaluating the efficacy or safety of the new oral anticogulants (NOACs) dabigatran, rivaroxaban, and apixaban for the prevention of stroke in patients with nonvalvular atrial fibrillation (AF).

          Related collections

          Author and article information

          Journal
          Value Health
          Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
          1524-4733
          1098-3015
          Mar 2015
          : 18
          : 2
          Affiliations
          [1 ] Mapi, Health Economics and Outcomes Research, Toronto, ON, Canada. Electronic address: scope@mapigroup.com.
          [2 ] Corporate Division Medicine, TA Cardiology, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; Center of Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
          [3 ] Boehringer Ingelheim, Paris, France.
          [4 ] Medical Data Services, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
          [5 ] Tufts University School of Medicine, Boston, MA, USA.
          Article
          S1098-3015(14)04738-X
          10.1016/j.jval.2014.10.012
          25773559
          Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

          Comments

          Comment on this article